Sensory nerve induced inflammation contributes to heterotopic ossification

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2748-2758

  Salisbury, Elizabeth ^a,b   Rodenberg, Eric ^a   Sonnet, Corinne ^a   Hipp, John ^b   Gannon, Francis H ^b   Vadakkan, Tegy J ^b   Dickinson, Mary E ^a,b   Olmsted Davis, Elizabeth A ^a,b   Davis, Alan R ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

bone morphogenetic protein type 2; heterotopic ossification; neural crest stem cells; neurogenic inflammation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITONIN GENE RELATED PEPTIDE; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HETEROTOPIC OSSIFICATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAST CELL; MOUSE; NEURITIS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE; CROMOLYN SODIUM; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEUROGENIC INFLAMMATION; OSSIFICATION, HETEROTOPIC; SENSORY RECEPTOR CELLS; SUBSTANCE P; TRPV CATION CHANNELS; X-RAY MICROTOMOGRAPHY;

ANIMALIA; MUS;

EID: 80053034418     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23225     Document Type: Article

References (67)

1. Adameyko I, Lallemend F, Aquino JB, Pereira JA, Topilko P, Muller T, Fritz N, Beljajeva A, Mochii M, Liste I, Usoskin D, Suter U, Birchmeier C, Ernfors P,. 2009. Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139: 366-379.
2. Anderson RM, Stottmann RW, Choi M, Klingensmith J,. 2006. Endogenous bone morphogenetic protein antagonists regulate mammalian neural crest generation and survival. Dev Dyn 235: 2507-2520. (Pubitemid 44325264)
3. Apel PJ, Crane D, Northam CN, Callahan M, Smith TL, Teasdall RD,. 2009. Effect of selective sensory denervation on fracture-healing: An experimental study of rats. J Bone Joint Surg Am 91: 2886-2895.
4. Baird EO, Kang QK,. 2009. Prophylaxis of heterotopic ossification-an updated review. J Orthop Surg Res 4: 12.
5. Beiner JM, Jokl P,. 2002. Muscle contusion injury and myositis ossificans traumatica. Clin Orthop Relat Res S110-S119. (Pubitemid 35345996)
6. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gallacher L, Dick JE,. 1999. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 189: 1139-1148.
7. Blasius AL, Brandl K, Crozat K, Xia Y, Khovananth K, Krebs P, Smart NG, Zampolli A, Ruggeri ZM, Beutler BA,. 2009. Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function. Proc Natl Acad Sci USA 106: 2706-2711.
8. Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J,. 1990. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate. Br J Pharmacol 99: 798-802. (Pubitemid 20111325)
9. Bucelli RC, Gonsiorek EA, Kim WY, Bruun D, Rabin RA, Higgins D, Lein PJ,. 2008. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther 324: 1172-1180. (Pubitemid 351397838)
10. Cavazzana AO, Miser JS, Jefferson J, Triche TJ,. 1987. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 127: 507-518. (Pubitemid 17089812)
11. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA,. 2003. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278: 45969-45977. (Pubitemid 37432744)
12. Cox JS,. 1967. Disodium cromoglycate (FPL 670) ('Intal'): A specific inhibitor of reaginic antibody-antigen mechanisms. Nature 216: 1328-1329.
13. Dilling CF, Wada AM, Lazard ZW, Salisbury EA, Gannon FH, Vadakkan TJ, Gao L, Hirschi K, Dickinson ME, Davis AR, Olmsted-Davis EA,. 2010. Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification. J Bone Miner Res 25: 1147-1156.
14. Ducy P, Karsenty G,. 2010. The two faces of serotonin in bone biology. J Cell Biol 191: 7-13.
15. Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, Tadaki D, Gage FA, Stojadinovic A, Elster EA,. 2009. Heterotopic ossification in high-energy wartime extremity injuries: Prevalence and risk factors. J Bone Joint Surg Am 91: 1084-1091.
16. Fouletier-Dilling CM, Bosch P, Davis AR, Shafer JA, Stice SL, Gugala Z, Gannon FH, Olmsted-Davis EA,. 2005. Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. Hum Gene Ther 16: 1287-1297. (Pubitemid 41611656)
17. Fouletier-Dilling CM, Gannon FH, Olmsted-Davis EA, Lazard Z, Heggeness MH, Shafer JA, Hipp JA, Davis AR,. 2007. Efficient and rapid osteoinduction in an immune-competent host. Hum Gene Ther 18: 733-745. (Pubitemid 47378070)
18. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G,. 2005. The molecular clock mediates leptin-regulated bone formation. Cell 122: 803-815. (Pubitemid 41242643)
19. Galli SJ, Grimbaldeston M, Tsai M,. 2008. Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478-486. (Pubitemid 351733419)
20. Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS,. 2001. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 32: 842-848. (Pubitemid 32803986)
21. Gugala Z, Olmsted-Davis EA, Gannon FH, Lindsey RW, Davis AR,. 2003. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 10: 1289-1296. (Pubitemid 36987119)
22. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R,. 2009. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462: 595-601.
23. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ,. 2005. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 65: 4633-4644. (Pubitemid 40740799)
24. Itoh S, Nakae S, Velotta JB, Kosuge H, Connolly A, Tsai M, Adachi H, Galli SJ, Robbins RC, Fischbein MP,. 2010. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. J Heart Lung Transplant 29: 401-409.
25. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH,. 2008. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10: 353-360. (Pubitemid 351331023)
26. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM,. 2002. Tissue origins and interactions in the mammalian skull vault. Dev Biol 241: 106-116. (Pubitemid 34066765)
27. Johnson D, Weiner HL, Seeldrayers PA,. 1988. Role of mast cells in peripheral nervous system demyelination. Ann NY Acad Sci 540: 727-728. (Pubitemid 19115478)
28. Johnson RC, Leopold JA, Loscalzo J,. 2006. Vascular calcification: Pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059. (Pubitemid 44729928)
29. Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG,. 2007. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89: 347-357. (Pubitemid 46214354)
30. Kaplan FS, Pignolo RJ, Shore EM,. 2009a. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev 20: 399-407.
31. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Koster B, Pauli RM, Reardon W, Zaidi SA, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM,. 2009b. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30: 379-390.
32. Khairatkar-Joshi N, Szallasi A,. 2009. TRPV1 antagonists: The challenges for therapeutic targeting. Trends Mol Med 15: 14-22.
33. Kichko TI, Reeh PW,. 2009. TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur J Neurosci 29: 1896-1904.
34. Kleij HP, Bienenstock J,. 2005. Significance of conversation between mast cells and nerves. Allergy Asthma Clin Immunol 1: 65-80. (Pubitemid 44369527)
35. Kolf CM, Cho E, Tuan RS,. 2007. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9: 204.
36. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP,. 2008. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123: 398-410. (Pubitemid 351171192)
37. Kwong FN, Harris MB,. 2008. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 16: 619-625.
38. Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, Glaser DL, Goldhamer DJ, Kaplan FS,. 2009. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 91: 652-663.
39. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR,. 2010. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16: 1400-1406.
40. Morrison SJ, White PM, Zock C, Anderson DJ,. 1999. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96: 737-749. (Pubitemid 29122815)
41. Motter AL, Ahern GP,. 2008. TRPV1-null mice are protected from diet-induced obesity. FEBS Lett 582: 2257-2262.
42. Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, Yagi R, Yagi K, Miyazaki J, Matoba R, Ko MS, Niwa H,. 2006. Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol 26: 7772-7782. (Pubitemid 44547722)
43. Olabisi RM, Lazard ZW, Franco CL, Hall MA, Kwon SK, Sevick-Muraca EM, Hipp JA, Davis AR, Olmsted-Davis EA, West JL,. 2010. Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification. Tissue Eng Part A 16: 3727-3736.
44. Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR,. 2007. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170: 620-632. (Pubitemid 47339399)
45. Olmsted-Davis EA, Gugala Z, Gannon FH, Yotnda P, McAlhany RE, Lindsey RW, Davis AR,. 2002. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther 13: 1337-1347. (Pubitemid 35034513)
46. Oury F, Yadav VK, Wang Y, Zhou B, Liu XS, Guo XE, Tecott LH, Schutz G, Means AR, Karsenty G,. 2010. CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev 24: 2330-2342.
47. Patapoutian A, Tate S, Woolf CJ,. 2009. Transient receptor potential channels: Targeting pain at the source. Nat Rev Drug Discov 8: 55-68.
48. Razavi R, Chan Y, Afifiyan FN, Liu XJ, Wan X, Yantha J, Tsui H, Tang L, Tsai S, Santamaria P, Driver JP, Serreze D, Salter MW, Dosch HM,. 2006. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 127: 1123-1135. (Pubitemid 44894522)
49. Richardson JD, Vasko MR,. 2002. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302: 839-845. (Pubitemid 34920202)
50. Salisbury E, Sonnet C, Heggeness M, Davis AR, Olmsted-Davis E,. 2010. Heterotopic ossification has some nerve. Critical reviews in eukaryotic gene expression 20: 313-324.
51. Schaible HG, Del Rosso A, Matucci-Cerinic M,. 2005. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 31: 77-101 ix. (Pubitemid 40082056)
52. Shi Y, Oury F, Yadav VK, Wess J, Liu XS, Guo XE, Murshed M, Karsenty G,. 2010. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab 11 (3): 231-238.
53. Shore EM, Kaplan FS,. 2010. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol 6 (9): 518-527.
54. Smadja DM, Bieche I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P,. 2008. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 28: 2137-2143.
55. Sottile V, Seuwen K,. 2000. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475: 201-204. (Pubitemid 30408453)
56. Sucosky P, Balachandran K, Elhammali A, Jo H, Yoganathan AP,. 2009. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol 29: 254-260.
57. Sviderskaya EV, Novak EK, Swank RT, Bennett DC,. 1998. The murine misty mutation: Phenotypic effects on melanocytes, platelets and brown fat. Genetics 148: 381-390. (Pubitemid 28063503)
58. Szallasi A, Cortright DN, Blum CA, Eid SR,. 2007. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6: 357-372. (Pubitemid 46705200)
59. Takeda S, Karsenty G,. 2008. Molecular bases of the sympathetic regulation of bone mass. Bone 42: 837-840.
60. Theoharides TC, Bondy PK, Tsakalos ND, Askenase PW,. 1982. Differential release of serotonin and histamine from mast cells. Nature 297: 229-231. (Pubitemid 12066450)
61. Theriault E, Otsuka M, Jessell T,. 1979. Capsaicin-evoked release of substance P from primary sensory neurons. Brain Res 170: 209-213. (Pubitemid 9195684)
62. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR,. 2008. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454: 1000-1004.
63. Urist MR,. 1965. Bone: Formation by autoinduction. Science 150: 893-899.
64. Vanden Bossche L, Vanderstraeten G,. 2005. Heterotopic ossification: A review. J Rehabil Med 37: 129-136. (Pubitemid 40775150)
65. Wang L, Wang DH,. 2005. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 112: 3617-3623. (Pubitemid 43739540)
66. Yanagita M,. 2009. BMP modulators regulate the function of BMP during body patterning and disease progression. Biofactors 35: 113-119.
67. Yano H, Wershil BK, Arizono N, Galli SJ,. 1989. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84: 1276-1286. (Pubitemid 19247601)